COMPANY PROFILE

Aker BioMarine

Request full access

A biotech and Antarctic krill harvesting company dedicated to improving human and planetary health

NorwayFounded 2002Biotech & Life Sciences

Revenue $100–500M Latest reported FY

Headcount 100–500 Current team size

Total funding $0–10M Disclosed equity funding

Unlock exact values

About Aker BioMarine

Aker BioMarine is a biotechnology company specializing in the development of krill-based bioactive ingredients. These ingredients are used in various markets, including nutraceuticals (health supplements), aquaculture (fish farming), and animal feed. The company operates a fully traceable value chain, starting from sustainable krill harvesting operations in Antarctica, through a logistics hub in Montevideo, and ending at a state-of-the-art factory in Houston. Aker BioMarine serves clients who are looking for high-quality, sustainable ingredients to enhance the health and performance of humans, fish, and pets. The business model focuses on sustainability and innovation, leveraging its expertise in krill harvesting to create value-added products. Revenue is generated through the sale of these specialized ingredients to manufacturers in the health, aquaculture, and pet food industries.

MoreLess Source: Dealroom company data

At a glance

Founded: 2002
Headquarters: Norway
Sector: Biotech & Life Sciences
Outcome tier: Thoroughbred$100M+ revenue

Knowledge graph

Founder mafias, market maps, lists and research connected to this company by Dealroom

Market map

Market map 350+ Nutraceutical startups

Open roles

Track hiring at Aker BioMarineOpen roles, team growth and hiring by functionBook a demo

Looking for a job? The startup jobs board lists open roles.Startups hiring now →

Aker BioMarine in its local ecosystem

Live from Dealroom

The Aker BioMarine office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

INInnovation Norway

Series B and later1 investor entered at this stage

AAAker ASA

Talent

Book a demo to see the people

Employees mapped 255 incl. 1 AI specialist

Founders /100 quality score

Key operators 21 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

20 countries with
team presence

🇺🇸 United States21.9%

🇵🇭 Philippines5.5%

🇪🇸 Spain2.4%

🇷🇺 Russia2.4%

🇦🇺 Australia2.4%

Top 5 of 20 shown

Web traffic by country

19K monthly visits
across markets

🇳🇴 Norway27.9%

🇺🇸 United States13.2%

🇦🇺 Australia6.8%

🇮🇳 India6.8%

🇬🇧 United Kingdom6.3%

Top 5 markets shown

Patents

Estimated portfolio value

$57M

34 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aker BioMarine on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aker BioMarine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles